Effectiveness and Impact of Autumn 2023 COVID‐19 Vaccination in Preventing Hospitalizations in Navarre, Spain, October 2023 to September 2024
CVE was moderate in preventing COVID-19 hospitalizations during the 2023-2024 season, but decreased 6 months after vaccination.
Authors
- Ana Navascués (ORCID: https://orcid.org/0000-0002-1372-9680)
- Guillermo Ezpeleta (ORCID: https://orcid.org/0000-0003-0970-6352)
- Miguel Fernández-Huerta (ORCID: https://orcid.org/0000-0002-1733-0925)
- Nerea Egüés
- María Eugenia Portillo (ORCID: https://orcid.org/0000-0002-4167-3645)
- Camino Trobajo‐Sanmartín (ORCID: https://orcid.org/0000-0001-5105-252X)
- Noelia Vera-Punzano (ORCID: https://orcid.org/0009-0000-8950-4560)
- Iván Martínez‐Baz (ORCID: https://orcid.org/0000-0002-3405-2277)
- Aitziber Echeverría (ORCID: https://orcid.org/0009-0002-2822-819X)
Institutions
- Instituto de Salud Pública de Navarra (ES)
- Complejo Hospitalario de Navarra (ES)
- Hospital Universitario de Gran Canaria Doctor Negrín (ES)
- Navarre Institute of Health Research (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- Universidad de Navarra (ES)
Publication Details
- Journal
- Influenza and Other Respiratory Viruses
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1111/irv.70163
- Citations
- 1
- Primary Topic
- Telemedicine and Telehealth Implementation
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- European Centre for Disease Prevention and Control
- Instituto de Salud Carlos III